Ironwood Pharmaceuticals | IRWD - Operating Profit


Ironwood Pharmaceuticals reported $33.22M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Acadia Pharmaceuticals USD 37.84M 42.45M Jun/2026
Agios Pharmaceuticals USD -110.02M 11.55M Mar/2026
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Almirall EUR 71.55M 41.32M Jun/2026
Alnylam Pharmaceuticals USD 112.6M 24.99M Jun/2026
Amarin USD -2.26M 564K Dec/2025
Ardelyx USD -32.79M 37.89M Mar/2026
Astellas Pharma JPY 185.36B 136.79B Jun/2026
AstraZeneca USD 3.16B 3.95B Jun/2026
Charles River Laboratories USD 119.89M 9K Jun/2026
Coherus Biosciences USD -39.08M 3.65M Dec/2025
Emergent BioSolutions USD -218M 69.9M Jun/2023
Halozyme Therapeutics USD -63.72M 1.95M Jun/2026
Incyte USD 700.4M 376.22M Jun/2026
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
Karyopharm Therapeutics USD -26.76M 8.92M Mar/2026
Lexicon Pharmaceuticals USD -14.78M 2.59M Dec/2025
MacroGenics USD -33.44M 21.34M Mar/2026
Moderna USD -815M 573M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Pacira USD 9.96M 5.33M Jun/2026
PTC Therapeutics USD 45.89M 127.51M Mar/2026
Puma Biotechnology USD 22.08M 24.26M Sep/2024
Sarepta Therapeutics USD 13.29M 345.14M Jun/2026
Takeda JPY 201.42B 215.04B Jun/2026
Ultragenyx Pharmaceutical USD -75M 141M Jun/2026
Vanda Pharmaceuticals USD -40.66M 29.66M Dec/2024